stoxline Quote Chart Rank Option Currency Glossary
  
(IDNA)
  0 (0%)    09-27 11:12
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:48:42 PM
Short term     
Mid term     
Targets 6-month :  27.22 1-year :  31.79
Resists First :  23.3 Second :  27.22
Pivot price 22.81
Supports First :  22.57 Second :  22.12
MAs MA(5) :  22.84 MA(20) :  22.74
MA(100) :  21.42 MA(250) :  22.16
MACD MACD :  0.1 Signal :  0.2
%K %D K(14,3) :  37.7 D(3) :  52.1
RSI RSI(14): 51.6
52-week High :  25.79 Low :  17.26
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ IDNA ] has closed above bottom band by 40.3%. Bollinger Bands are 46.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 22.79 - 22.93 22.93 - 23.06
Low: 22.05 - 22.21 22.21 - 22.37
Close: 22.48 - 22.72 22.72 - 22.95
Company Description

Headline News

Thu, 04 Sep 2025
CSE flags iDNA Genomics shares over auditor concerns for 2024 - MSN

Fri, 29 Aug 2025
Occupation Forces Bulldoze Citizens' Lands in Idna Town - وكالة صدى نيوز

Tue, 22 Jul 2025
How one Israeli company controls - and cuts off - Palestinians’ access to water in the West Bank - mondoweiss.net

Mon, 19 May 2025
Improving the Understanding of Detections From iDNA Surveys in Malaysian Borneo With Multiscale Occupancy Models: A Case-Study Using Leech Blood Meals - Wiley Online Library

Sun, 20 Apr 2025
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (NYSEARCA:IDNA) - Seeking Alpha

Mon, 18 Nov 2024
Living Microbes Discovered In Earth’s Driest Desert - astrobiology.com

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android